These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34303789)
1. Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition. Savira F; Magaye R; Scullino CV; Flynn BL; Pitson SM; Anderson D; Creek DJ; Hua Y; Xiong X; Huang L; Liew D; Reid C; Kaye D; Kompa AR; Wang BH Toxicol Lett; 2021 Oct; 350():133-142. PubMed ID: 34303789 [TBL] [Abstract][Full Text] [Related]
2. The effect of dihydroceramide desaturase 1 inhibition on endothelial impairment induced by indoxyl sulfate. Savira F; Kompa AR; Kelly DJ; Magaye R; Xiong X; Huang L; Liew D; Reid C; Kaye D; Scullino CV; Pitson SM; Flynn BL; Wang BH Vascul Pharmacol; 2021 Dec; 141():106923. PubMed ID: 34600152 [TBL] [Abstract][Full Text] [Related]
3. Ablation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitro. Siddique MM; Bikman BT; Wang L; Ying L; Reinhardt E; Shui G; Wenk MR; Summers SA PLoS One; 2012; 7(9):e44042. PubMed ID: 22984457 [TBL] [Abstract][Full Text] [Related]
4. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome. van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776 [TBL] [Abstract][Full Text] [Related]
5. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins. Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233 [TBL] [Abstract][Full Text] [Related]
6. Exploring binding characteristics and the related competition of different protein-bound uremic toxins. Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271 [TBL] [Abstract][Full Text] [Related]
14. Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population. Snauwaert E; Holvoet E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Godefroid N; Krid S; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Van Dyck M; Van Hoeck K; Collard L; Eloot S; Shroff R Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 31022857 [TBL] [Abstract][Full Text] [Related]
15. Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro. Yamamoto S; Ito T; Sato M; Goto S; Kazama JJ; Gejyo F; Narita I Blood Purif; 2019; 48(3):215-222. PubMed ID: 31055586 [TBL] [Abstract][Full Text] [Related]
16. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets. Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632 [TBL] [Abstract][Full Text] [Related]
17. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis. Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401 [TBL] [Abstract][Full Text] [Related]
18. pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro. Yamamoto S; Sasahara K; Domon M; Yamaguchi K; Ito T; Goto S; Goto Y; Narita I Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33557434 [TBL] [Abstract][Full Text] [Related]